Joel Lewis, President and CEO of Galectin Therapeutics Inc. ($GALT), sold shares on the open market 11 times over the past year, totaling about $710,000. His most recent sale occurred on January 6, 2026. These GALT insider sales rank 5,709th among nearly 12,000 individual insiders, compared to an average of $8.6 million per seller and 6.4 transactions. Lewis made no open market purchases in the last 365 days.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 16, 2026 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | A | Stock option (right to buy) | 91000 | $0.00 | 91,000.0000 | 63,180,491 | 9999.99% | 0.14% |
| Jan. 16, 2026 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | A | Stock option (right to buy) | 84000 | $0.00 | 65,000.0000 | 63,180,491 | 0.00% | 0.13% |
| Jan. 16, 2026 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | A | Restricted Stock Unit | 120000 | $0.00 | 100,000.0000 | 63,180,491 | 0.00% | 0.19% |
| Jan. 5, 2026 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 27731 | $3.91 | 872,290.0000 | 63,180,491 | 3.08% | 0.04% |
| Jan. 2, 2026 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Common Stock | 84000 | $0.00 | 918,592.0000 | 63,180,491 | 10.06% | 0.13% |
| Jan. 2, 2026 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 18571 | $4.20 | 900,021.0000 | 63,180,491 | 2.02% | 0.03% |
| Jan. 2, 2026 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Restricted Stock Unit | 84000 | $0.00 | 0.0000 | 63,180,491 | 100.00% | 0.13% |
| Jan. 6, 2026 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 37698 | $3.58 | 834,592.0000 | 63,180,491 | 4.32% | 0.06% |
| Dec. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 7829 | $7.06 | 834,592.0000 | 63,180,491 | 0.93% | 0.01% |
| Dec. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Stock option (right to buy) | 7829 | $0.00 | 32,171.0000 | 63,180,491 | 19.57% | 0.01% |
| Dec. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Common Stock | 7829 | $2.86 | 842,421.0000 | 63,180,491 | 0.94% | 0.01% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Common Stock | 15680 | $2.39 | 850,272.0000 | 63,180,491 | 1.88% | 0.02% |
| Nov. 18, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Stock option (right to buy) | 6783 | $0.00 | 0.0000 | 63,180,491 | 100.00% | 0.01% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Stock option (right to buy) | 15680 | $0.00 | 6,783.0000 | 63,180,491 | 69.80% | 0.02% |
| Nov. 18, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 6783 | $6.15 | 834,592.0000 | 63,180,491 | 0.81% | 0.01% |
| Nov. 18, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Common Stock | 6783 | $2.39 | 841,375.0000 | 63,180,491 | 0.81% | 0.01% |
| Nov. 17, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 15680 | $6.04 | 834,592.0000 | 63,180,491 | 1.84% | 0.02% |
| Nov. 10, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Common Stock | 1867 | $2.39 | 836,459.0000 | 63,180,491 | 0.22% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Stock option (right to buy) | 1867 | $0.00 | 22,363.0000 | 63,180,491 | 7.71% | 0.00% |
| Nov. 10, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 1867 | $6.03 | 834,592.0000 | 63,180,491 | 0.22% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 200 | $6.00 | 834,592.0000 | 63,180,491 | 0.02% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Common Stock | 200 | $2.39 | 834,792.0000 | 63,180,491 | 0.02% | 0.00% |
| Nov. 5, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Stock option (right to buy) | 200 | $0.00 | 24,230.0000 | 63,180,491 | 0.82% | 0.00% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Common Stock | 1300 | $2.39 | 835,892.0000 | 63,180,491 | 0.16% | 0.00% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Stock option (right to buy) | 14420 | $0.00 | 24,530.0000 | 63,180,491 | 37.02% | 0.02% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Stock option (right to buy) | 1300 | $0.00 | 38,950.0000 | 63,180,491 | 3.23% | 0.00% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 14420 | $6.07 | 834,592.0000 | 63,180,491 | 1.70% | 0.02% |
| Nov. 4, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Common Stock | 14420 | $2.39 | 849,012.0000 | 63,180,491 | 1.73% | 0.02% |
| Nov. 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 1300 | $6.01 | 834,592.0000 | 63,180,491 | 0.16% | 0.00% |
| Sept. 12, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Common Stock | 14000 | $2.39 | 848,592.0000 | 63,180,491 | 1.68% | 0.02% |
| Sept. 12, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Stock option (right to buy) | 14000 | $2.39 | 40,250.0000 | 63,180,491 | 25.81% | 0.02% |
| Sept. 12, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 14000 | $6.36 | 834,592.0000 | 63,180,491 | 1.65% | 0.02% |
| March 3, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | A | Common Stock | 56420 | $1.57 | 834,592.0000 | 0 | 6.33% | 0.00% |
| Jan. 23, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | A | Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2025 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | A | Restricted Stock Unit | 84000 | $0.00 | 84,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 23, 2024 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Common Stock | 56000 | $0.00 | 955,012.0000 | 0 | 6.23% | 0.00% |
| Dec. 23, 2024 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | M | Restricted Stock Units | 56000 | $0.00 | 0.0000 | 0 | 0.00% | 0.00% |
| Dec. 23, 2024 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | S | Common Stock | 56000 | $0.89 | 899,012.0000 | 0 | 5.86% | 0.00% |
| April 24, 2024 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | P | Common Stock | 1000 | $3.39 | 899,012.0000 | 0 | 0.11% | 0.00% |
| March 1, 2024 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | A | Common Stock | 152584 | $1.96 | 897,716.0000 | 0 | 14.53% | 0.00% |
| Jan. 24, 2024 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | A | Restricted Stock Unit | 56000 | $0.00 | 56,000.0000 | 0 | 9999.99% | 0.00% |
| Jan. 24, 2024 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | A | Stock Option (right to buy) | 91000 | $0.00 | 91,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 29, 2023 | GALECTIN THERAPEUTICS INC | $GALT | LEWIS JOEL | President and CEO | A | Common Stock | 11606 | $1.66 | 1,042,300.0000 | 0 | 1.13% | 0.00% |